7.3 Heart Transplant and Post-Op Care/Risks Flashcards

1
Q

Organ Transplants

A
  • Used for End Stage Diseases

Indications
- Ischemic Cardiomyopathy
- Idiopathic Cardiomyopathy
- Valvular Heart Disease
- Congenital Anomalies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Patient Evaluation

A

General
- Treatment begins during evaluation phase
- The goal is to have the patient in the best physical condition for transplant, this includes adequate nutrition, mobility, and muscle strength.

Age
- BIOLOGIC AGE (how well they function) NOT CHRONOLOGIC AGE (how old they are)
- Anywhere between infant to 70
- Age 55+ is increased risk

ABSENCE OF INFECTION
- No infections before transplants
- Localized liver infections CAN BE AN EXCEPTION
- Inflammatory diseases do not rule out transplants (lupus) but should be dormant (quiescent) during procedure)

Health
- ABO Typing
- Matching
- Transfusion History
- Infectious disease screening
- Liver/Renal Function Tests
- CBC
- Coagulation studies
- GI Evaluation
- Gynecology
- ECG
- Dental Exam for Infection
- Social History

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Criteria

A
  • Put on UNOS list based on blood type and listing data
  • Size of organ is important
  • Patients require heart transplants AND inotropic medications or ventricular assistance are at higher priority

Requirements (any of the below)
- Cardiac Disease
- Not treatable with other interventions
- Less than 25% survival at the end of the year without transplant
- Fatal dysrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Contraindications for Heart Transplant

A
  • Fixed pulmonary hypertension
    PVC - greater than 6-8 Wood Units
  • Recently unsolved pulmonary infarct (increases risk of infection)
  • Poorly controlled diabetes mellitus
  • Right heart catheterization or full
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Evaluation for Transplant

A
  • Cardiopulmonary Exercise Test (MVO2)
  • Pulmonary function tests (diffusion capacity - DLCO)
  • Cardiac Rehabilitation consultant
  • Multigated Acquisition (MUGA) or Echocardiogram
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Donor Selection

A
  • Must be ABO compatible

Tissue Typing
- Histocompatibility testing (tissue typing)
- Identification of donor antigens verse recipient antibodies which predicts graft acceptance

HLA
- Major histocompatibility complex
- Class 1 antigen - Present on surface of all nucleated cells and platelets.
- Class 2 antigen - Found on surface of lymphocytes
- Each person has 6 (A-, B-, DR- Antigens)
- The higher number of matching antigens, the higher likelihood of compatibility.
- 6 Antigen match is the best

PRA
- When patients are receiving a non-living donation a pool of random donors is tested against the recipient.
- The higher the percentage of samples the patient reacts to (Panel Reactive Antibody - PRA percentage) - the higher the risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Blood Transfusions

A
  • Avoided in patients awaiting heart transplants due to risk of antibody production which results in high PRA or positive cross-match between donor and recipient.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Orthotopic Transplants

A
  • Classic and most common transplant
  • Heart is taken out of recipient and replaced with donors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lower and Shumway Technique

A
  • Gold Standard
  • Atrial to Atrial Cuff

Complications
- Mitral/Tricuspid Regurgitation
- Atrial Thrombus Formation
- Tachydysrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bicaval Technique

A
  • Preserves anatomy of atrium
  • Anastomoses is between inferior and superior vena cava instead of atria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Heterotopic Transplant

A
  • Piggyback Procedure
  • Recipient heart is left in place and donor heart is placed next to it in the right chest.
  • 2 Hearts are then connected together.

Indications
- Patients with pulmonary hypertension
- Can also be used in an emergency if donor heart is too small for the recipient

Limitations
- Thromboembolism from native heart would need anticoagulation
- Limited chest space
- Survival rates are lower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

POST OP CARE

A
  • VS
  • Oxygen
  • Ventilator settings
  • LOC and degree of pain
  • Note number of IV and arterial lines
  • Note site, type of solution and flowrate
  • Note presence of drainage and amount/type
  • Presence of catheters, patency, and urinary drainage
  • Appropriate amount and character of NG tube drainage
  • Most recent hemodynamic and intraoperative laboratory results
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

POST OP CARE (HEART)

A
  • There maybe 2 P waves on ECG
  • Denervation (loss of nerve supply) may cause high HR, sympathetic stimulation may be absent, medications on autonomic nervous system may have abnormal effects
  • Potential ventricular failure (treat with medications to decrease right heart afterload)

Denervation
- Medication effects are abnormal
- Atropine does not work
- Use Dobutamine and Epinephrine with Epicardial Pacing instead of Isoproterenol to manage bradydysrhythmias
- Digitalis does not work because it is mediated by the parasympathetic nervous system

  • PATIENT DOES NOT FEEL PAIN (ischemia or MI can go unnoticed) - ECG stress tests and coronary angiographs are preformed

Right Sided HF Treatment
- Drugs to decrease right side afterload (dobutamine, milrinone, inhaled nitrous oxide)
- Nitrous oxide is a pulmonary vasodilator
- Administered via lungs so it avoids systemic effects administered IV.

Risk Factors for Right Side HF
- Hypoxia
- Acidosis
- Excessive Blood Transfusions (AVOID)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Immunosuppressive Therapy

A
  • Immunosuppression to prevent rejection
  • Goals are to avoid toxicity, unfavorable reactions, and reduce susceptibility to opportunistic infections

Triple Therapy
- Prednisone, Azathioprine, Cyclosporine/Tacrolimus

Quadruple Therapy
- Same as above and antithymocyte antibody or monoclonal antibody (monomurab)

Induction and Maintenance

Induction - Immediately after transplant, high dose of immunosuppression
Maintenance - Lower dose once stable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Complications of Immunosuppression

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hyperacute Rejection

A
  • Occurs in operating room immediately after transplant
  • Humoral response where recipient antibodies immediately react against antigens of donated organ
  • This causes vascular damage which results in severe thrombosis and graft necrosis.
  • HEART AND KIDNEYS THIS ALWAYS RESULTS IN GRAFT FAILURE AND REQUIRES RETRANSPLANTATION
  • PREVENTED BY PRETRANSPLANT CROSSMATCHING
17
Q

Accelerated Rejection

A
  • Only in Kidney Transplants
  • Occurs within 1 week
  • Antigen-Antibody Response
18
Q

Acute Rejection

A
  • Occurs within first 3 months
  • Most common rejection
  • Respond with immunotherapy
  • Major cause of death in the first year of transplant

Pathophysiology
- Donor organ triggers lymphocytes to turn into helper t cells and cytotoxic t cells which damage transplanted organ by secreting lysosomal enzymes and lymphokines

  • Often asymptomatic but may cause decreased cardiac output, A-Flutter/A-Fib, elevated WBC, Low grade fever.
  • Endomyocardial biopsy done weekly for the first month to diagnose rejection
19
Q

Chronic Rejection

A
  • Combination of cell mediated and circulating antibodies.
  • Occurs 3 months to a year after transplant
  • Causes deterioration of organ function
20
Q

Infection

A
  • Most common complication post-transplant
  • Pretransplant alterations in mucosal barriers conduct opportunistic infection
  • Usually caused by patients own flora (particularly GI tract and integumentary system)
  • Opportunistic pathogens are usually harmless and naturally found in humans, but pose serious threat in compromised immune systems.
  • They take advantage of decreased host defenses
  • HIGH RISK OF INFECTION FOR THE FIRST 3 MONTHS DUE TO HIGH DOSE IMMUNOSUPPRESSANTS
  • After the first month the most common infection is CMV
  • Prevention of CMV is imperative due to connection between CMV and coronary artery disease
21
Q

Bleeding

A
  • Surgical site
  • Hematoma
  • Lymphocele
  • Due to long term coagulation therapy, liver dysfunction, or Post-Op Hematuria
22
Q

GI Complications

A
  • Related to steroid therapy
  • Increased risk of peptic ulcers and erosive gastritis
  • PPI and H2 Blockers to Treat